Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
life sciences
national blog main
san francisco blog main
3
×
boston
boston top stories
deals
fda
national top stories
new york blog main
new york top stories
san francisco top stories
startups
vc
accent therapeutics
aducanumab
akouos
alzheimer's disease
amblyotech
asklepios biopharmaceutical
astellas pharmaceuticals
azacitidine
beta-thalassemia
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
california institute for biomedical research
cancer
cara therapeutics
clinical trials
dacogen
decibel therapeutics
decitabine
deerfield management
detroit blog main
What
developing
3
×
medicines
3
×
fda
ipo
new
therapeutics
activity
affects
aims
americans
approach
approvals
approved
based
bio
biogen
biotech
called
clamped
covid
date
debuts
delays
drug
drugs
economic
epigenetic
epigenetics
fast
field
flagship’s
frequency
hearing
including
isn’t
loss
lot
meds
millions
morning
Language
unset
Current search:
biotech
×
developing
×
" san francisco blog main "
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
